ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Nature Immunology Année : 2023

ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment

Javiera Villar
Adeline Cros
  • Fonction : Auteur
Alba de Juan
  • Fonction : Auteur
Pierre-Emmanuel Bonte
Ioanna Tiniakou
Boris Reizis
Elodie Segura
  • Fonction : Auteur
  • PersonId : 943749

Résumé

In inflamed tissues, monocytes differentiate into macrophages (mo-Macs) or dendritic cells (mo-DCs). In chronic nonresolving inflammation, mo-DCs are major drivers of pathogenic events. Manipulating monocyte differentiation would therefore be an attractive therapeutic strategy. However, how the balance of mo-DC versus mo-Mac fate commitment is regulated is not clear. In the present study, we show that the transcriptional repressors ETV3 and ETV6 control human monocyte differentiation into mo-DCs. ETV3 and ETV6 inhibit interferon (IFN)-stimulated genes; however, their action on monocyte differentiation is independent of IFN signaling. Instead, we find that ETV3 and ETV6 directly repress mo-Mac development by controlling MAFB expression. Mice deficient for Etv6 in monocytes have spontaneous expression of IFN-stimulated genes, confirming that Etv6 regulates IFN responses in vivo. Furthermore, these mice have impaired mo-DC differentiation during inflammation and reduced pathology in an experimental autoimmune encephalomyelitis model. These findings provide information about the molecular control of monocyte fate decision and identify ETV6 as a therapeutic target to redirect monocyte differentiation in inflammatory disorders.
Fichier principal
Vignette du fichier
Villar Nat Immunol 2022.pdf (18.43 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

inserm-03994135 , version 1 (17-02-2023)

Licence

Identifiants

Citer

Javiera Villar, Adeline Cros, Alba de Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, et al.. ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature Immunology, 2023, 24 (1), pp.84-95. ⟨10.1038/s41590-022-01374-0⟩. ⟨inserm-03994135⟩
27 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More